Literature DB >> 311458

Flunarizine and cinnarizine as vestibular depressants. A statistical study.

P L Mangabeira-Albernaz, M M Ganança, N F Novo, E R de Paiva.   

Abstract

The authors analysed the vestibular depressant activity of flunarizine and cinnarizine, as compared to a placebo, in 58 patients with peripheral labyrinthine disorders. The activity of the medications was judged by the reduction of the average velocity of the slow phase of the post-caloric nystagmus, before and after treatment. In spite of being administered in a smaller dosis, flunarizine appeared to have a more intense vestibular supressant activity, as judged by different statistical tests.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 311458     DOI: 10.1159/000275391

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  5 in total

Review 1.  Ménière's disease. A practical approach to management.

Authors:  G B Brookes
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

Review 2.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

3.  Cinnarizine: A Contemporary Review.

Authors:  Milind Vasant Kirtane; Anita Bhandari; Prashant Narang; Ravi Santani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-04-25

Review 4.  Interpretation and use of caloric testing.

Authors:  Denise Utsch Gonçalves; Lilian Felipe; Tânia Mara Assis Lima
Journal:  Braz J Otorhinolaryngol       Date:  2008 May-Jun

5.  Optimizing the pharmacological component of integrated balance therapy.

Authors:  Maurício Malavasi Ganança; Heloisa Helena Caovilla; Mário Sérgio Lei Munhoz; Cristina Freitas Ganança; Maria Leonor Garcia da Silva; Flavio Serafini; Fernando Freitas Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2007 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.